|4Apr 15, 5:53 PM ET

Bornstein Jonathan 4

4 · Amprius Technologies, Inc. · Filed Apr 15, 2024

Insider Transaction Report

Form 4
Period: 2024-04-12
Bornstein Jonathan
President of Amprius Lab
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-04-121,007,8671 total
    Exercise: $0.05From: 2022-09-14Exp: 2027-03-15Common stock (1,007,867 underlying)
  • Exercise/Conversion

    Common stock

    2024-04-12$0.05/sh+1,007,867$50,3931,566,797 total
Footnotes (1)
  • [F1]Includes 558,930 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock, subject to the applicable vesting schedule and conditions of each restricted stock unit.

Documents

1 file
  • 4
    wk-form4_1713218014.xmlPrimary

    FORM 4